Skip to main content
Top
Published in: Insights into Imaging 1/2023

Open Access 01-12-2023 | Metastasis | Original Article

MRI feature-based radiomics models to predict treatment outcome after stereotactic body radiotherapy for spinal metastases

Authors: Yongye Chen, Siyuan Qin, Weili Zhao, Qizheng Wang, Ke Liu, Peijin Xin, Huishu Yuan, Hongqing Zhuang, Ning Lang

Published in: Insights into Imaging | Issue 1/2023

Login to get access

Abstract

Objective

This study aimed to extract radiomics features from MRI using machine learning (ML) algorithms and integrate them with clinical features to build response prediction models for patients with spinal metastases undergoing stereotactic body radiotherapy (SBRT).

Methods

Patients with spinal metastases who were treated using SBRT at our hospital between July 2018 and April 2023 were recruited. We assessed their response to treatment using the revised Response Evaluation Criteria in Solid Tumors (version 1.1). The lesions were categorized into progressive disease (PD) and non-PD groups. Radiomics features were extracted from T1-weighted image (T1WI), T2-weighted image (T2WI), and fat-suppression T2WI sequences. Feature selection involved intraclass correlation coefficients, minimal-redundancy-maximal-relevance, and least absolute shrinkage and selection operator methods. Thirteen ML algorithms were employed to construct the radiomics prediction models. Clinical, conventional imaging, and radiomics features were integrated to develop combined models. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, and the clinical value was assessed using decision curve analysis.

Results

We included 194 patients with 142 (73.2%) lesions in the non-PD group and 52 (26.8%) in the PD group. Each region of interest generated 2264 features. The clinical model exhibited a moderate predictive value (area under the ROC curve, AUC = 0.733), while the radiomics models demonstrated better performance (AUC = 0.745–0.825). The combined model achieved the best performance (AUC = 0.828).

Conclusion

The MRI-based radiomics models exhibited valuable predictive capability for treatment outcomes in patients with spinal metastases undergoing SBRT.

Critical relevance statement

Radiomics prediction models have the potential to contribute to clinical decision-making and improve the prognosis of patients with spinal metastases undergoing SBRT.

Key points

• Stereotactic body radiotherapy effectively delivers high doses of radiation to treat spinal metastases.
• Accurate prediction of treatment outcomes has crucial clinical significance.
• MRI-based radiomics models demonstrated good performance to predict treatment outcomes.

Graphical Abstract

Literature
1.
2.
go back to reference Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–1075CrossRefPubMedPubMedCentral Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–1075CrossRefPubMedPubMedCentral
3.
go back to reference Glicksman RM, Tjong MC, Neves-Junior WFP et al (2020) Stereotactic ablative radiotherapy for the management of spinal metastases: a review. JAMA Oncol 6:567–577CrossRefPubMed Glicksman RM, Tjong MC, Neves-Junior WFP et al (2020) Stereotactic ablative radiotherapy for the management of spinal metastases: a review. JAMA Oncol 6:567–577CrossRefPubMed
4.
go back to reference Thibault I, Chang EL, Sheehan J et al (2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol 16:e595–603CrossRefPubMed Thibault I, Chang EL, Sheehan J et al (2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol 16:e595–603CrossRefPubMed
6.
go back to reference Kowalchuk RO, Waters MR, Richardson KM et al (2020) Stereotactic radiosurgery for the treatment of bulky spine metastases. J Neurooncol 148:381–388CrossRefPubMed Kowalchuk RO, Waters MR, Richardson KM et al (2020) Stereotactic radiosurgery for the treatment of bulky spine metastases. J Neurooncol 148:381–388CrossRefPubMed
7.
go back to reference Husain ZA, Sahgal A, De Salles A et al (2017) Stereotactic body radiotherapy for de novo spinal metastases: systematic review. J Neurosurg Spine 27:295–302CrossRefPubMed Husain ZA, Sahgal A, De Salles A et al (2017) Stereotactic body radiotherapy for de novo spinal metastases: systematic review. J Neurosurg Spine 27:295–302CrossRefPubMed
8.
go back to reference Sahgal A, Larson DA, Chang EL (2008) Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 71:652–665CrossRefPubMed Sahgal A, Larson DA, Chang EL (2008) Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 71:652–665CrossRefPubMed
9.
go back to reference Sahgal A, Bilsky M, Chang EL et al (2011) Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient. J Neurosurg Spine 14:151–166CrossRefPubMed Sahgal A, Bilsky M, Chang EL et al (2011) Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient. J Neurosurg Spine 14:151–166CrossRefPubMed
10.
go back to reference Zeng KL, Sahgal A, Tseng CL et al (2021) Prognostic factors associated with surviving less than 3 months vs greater than 3 years specific to spine stereotactic body radiotherapy and late adverse events. Neurosurgery 88:971–979CrossRefPubMedPubMedCentral Zeng KL, Sahgal A, Tseng CL et al (2021) Prognostic factors associated with surviving less than 3 months vs greater than 3 years specific to spine stereotactic body radiotherapy and late adverse events. Neurosurgery 88:971–979CrossRefPubMedPubMedCentral
11.
go back to reference Zeng KL, Sahgal A, Husain ZA et al (2021) Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference. J Neurooncol 152:173–182CrossRefPubMed Zeng KL, Sahgal A, Husain ZA et al (2021) Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference. J Neurooncol 152:173–182CrossRefPubMed
12.
go back to reference Park HJ, Kim HJ, Won JH, Lee SC, Chang AR (2015) Stereotactic body radiotherapy (SBRT) for spinal metastases: who will benefit the most from SBRT? Technol Cancer Res Treat 14:159–167CrossRefPubMed Park HJ, Kim HJ, Won JH, Lee SC, Chang AR (2015) Stereotactic body radiotherapy (SBRT) for spinal metastases: who will benefit the most from SBRT? Technol Cancer Res Treat 14:159–167CrossRefPubMed
13.
go back to reference Chao ST, Koyfman SA, Woody N et al (2012) Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys 82:1738–1743CrossRefPubMed Chao ST, Koyfman SA, Woody N et al (2012) Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys 82:1738–1743CrossRefPubMed
14.
go back to reference Prins FM, van der Velden JM, Gerlich AS et al (2017) Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT. Ann Palliat Med 6:S147–s154CrossRefPubMed Prins FM, van der Velden JM, Gerlich AS et al (2017) Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT. Ann Palliat Med 6:S147–s154CrossRefPubMed
15.
go back to reference Avanzo M, Wei L, Stancanello J et al (2020) Machine and deep learning methods for radiomics. Med Phys 47:e185–e202CrossRefPubMed Avanzo M, Wei L, Stancanello J et al (2020) Machine and deep learning methods for radiomics. Med Phys 47:e185–e202CrossRefPubMed
16.
go back to reference Cox BW, Spratt DE, Lovelock M et al (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:e597–605CrossRefPubMed Cox BW, Spratt DE, Lovelock M et al (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:e597–605CrossRefPubMed
17.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed
18.
go back to reference Karcioglu O, Topacoglu H, Dikme O, Dikme O (2018) A systematic review of the pain scales in adults: which to use? Am J Emerg Med 36:707–714CrossRefPubMed Karcioglu O, Topacoglu H, Dikme O, Dikme O (2018) A systematic review of the pain scales in adults: which to use? Am J Emerg Med 36:707–714CrossRefPubMed
19.
go back to reference Puvanesarajah V, Lo SL, Aygun N et al (2015) Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy. J Neurosurg Spine 23:620–629CrossRefPubMedPubMedCentral Puvanesarajah V, Lo SL, Aygun N et al (2015) Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy. J Neurosurg Spine 23:620–629CrossRefPubMedPubMedCentral
20.
go back to reference Fisher CG, DiPaola CP, Ryken TC et al (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 35:E1221–1229CrossRefPubMed Fisher CG, DiPaola CP, Ryken TC et al (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 35:E1221–1229CrossRefPubMed
21.
go back to reference Bilsky MH, Laufer I, Fourney DR et al (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13:324–328CrossRefPubMed Bilsky MH, Laufer I, Fourney DR et al (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13:324–328CrossRefPubMed
22.
go back to reference Zwanenburg A, Leger S, Vallières M, Lck SJR, Oncology (2016) Image biomarker standardisation initiative Zwanenburg A, Leger S, Vallières M, Lck SJR, Oncology (2016) Image biomarker standardisation initiative
23.
go back to reference Peng H, Long F, Ding C (2005) Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 27:1226–1238CrossRefPubMed Peng H, Long F, Ding C (2005) Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 27:1226–1238CrossRefPubMed
25.
go back to reference Tree AC, Khoo VS, Eeles RA et al (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14:e28–37CrossRefPubMed Tree AC, Khoo VS, Eeles RA et al (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14:e28–37CrossRefPubMed
26.
go back to reference Luksanapruksa P, Buchowski JM, Hotchkiss W, Tongsai S, Wilartratsami S, Chotivichit A (2017) Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis. Spine J 17:689–708CrossRefPubMed Luksanapruksa P, Buchowski JM, Hotchkiss W, Tongsai S, Wilartratsami S, Chotivichit A (2017) Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis. Spine J 17:689–708CrossRefPubMed
27.
go back to reference Jabbari S, Gerszten PC, Ruschin M, Larson DA, Lo SS, Sahgal A (2016) Stereotactic body radiotherapy for spinal metastases: Practice Guidelines, Outcomes, and Risks. Cancer J 22:280–289CrossRefPubMed Jabbari S, Gerszten PC, Ruschin M, Larson DA, Lo SS, Sahgal A (2016) Stereotactic body radiotherapy for spinal metastases: Practice Guidelines, Outcomes, and Risks. Cancer J 22:280–289CrossRefPubMed
28.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
30.
go back to reference Uribe CF, Mathotaarachchi S, Gaudet V et al (2019) Machine learning in nuclear medicine: Part 1-Introduction. J Nucl Med 60:451–458CrossRefPubMed Uribe CF, Mathotaarachchi S, Gaudet V et al (2019) Machine learning in nuclear medicine: Part 1-Introduction. J Nucl Med 60:451–458CrossRefPubMed
31.
go back to reference Rasmussen CE, Williams C (2006) Gaussian Process for Machine Learning Rasmussen CE, Williams C (2006) Gaussian Process for Machine Learning
33.
go back to reference Yamada Y, Katsoulakis E, Laufer I et al (2017) The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus 42:E6CrossRefPubMedPubMedCentral Yamada Y, Katsoulakis E, Laufer I et al (2017) The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus 42:E6CrossRefPubMedPubMedCentral
34.
go back to reference Wakabayashi K, Koide Y, Aoyama T et al (2021) A predictive model for pain response following radiotherapy for treatment of spinal metastases. Sci Rep 11:12908CrossRefPubMedPubMedCentral Wakabayashi K, Koide Y, Aoyama T et al (2021) A predictive model for pain response following radiotherapy for treatment of spinal metastases. Sci Rep 11:12908CrossRefPubMedPubMedCentral
Metadata
Title
MRI feature-based radiomics models to predict treatment outcome after stereotactic body radiotherapy for spinal metastases
Authors
Yongye Chen
Siyuan Qin
Weili Zhao
Qizheng Wang
Ke Liu
Peijin Xin
Huishu Yuan
Hongqing Zhuang
Ning Lang
Publication date
01-12-2023
Publisher
Springer Vienna
Published in
Insights into Imaging / Issue 1/2023
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-023-01523-5

Other articles of this Issue 1/2023

Insights into Imaging 1/2023 Go to the issue